QCMC
BMRN icon

Quantum Capital Management (California)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quantum Capital Management (California)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,885
Closed -$501K – 154
2018
Q4 		$501K Sell
5,885
-37,157
-86% -$3.53M 0.29% 87
2018
Q3 		$4.17M Sell
43,042
-2,853
-6% -$285K 1.49% 9
2018
Q2 		$4.32M Sell
45,895
-80,974
-64% -$7.09M 1.66% 4
2018
Q1 		$10.3M Buy
126,869
+17,171
+16% +$1.47M 2.48% 5
2017
Q4 		$9.78M Buy
109,698
+14,461
+15% +$1.26M 2.34% 6
2017
Q3 		$8.86M Sell
95,237
-11,533
-11% -$1.02M 2.09% 11
2017
Q2 		$9.7M Sell
106,770
-13
-0% -$1.18K 2.39% 9
2017
Q1 		$9.37M Buy
106,783
+12,995
+14% +$1.16M 2.33% 9
2016
Q4 		$7.77M Buy
93,788
+25,270
+37% +$2.17M 2.09% 13
2016
Q3 		$6.34M Sell
68,518
-96,996
-59% -$9.13M 1.77% 22
2016
Q2 		$12.9M Sell
165,514
-7,292
-4% -$620K 1.82% 29
2016
Q1 		$14.3M Buy
172,806
+85,476
+98% +$6.95M 1.93% 24
2015
Q4 		$9.15M Buy
+87,330
New +$9.12M 1.19% 38
2015
Q2 		– Sell
-84,145
Closed -$6.07M – 164
2015
Q1 		$6.07M Buy
84,145
+2,224
+3% +$236K 1.33% 35
2014
Q4 		$7.41M Sell
81,921
-8,400
-9% -$699K 1.69% 25
2014
Q3 		$6.52M Sell
90,321
-6,995
-7% -$460K 1.28% 31
2014
Q2 		$6.05M Sell
97,316
-12,521
-11% -$756K 1.03% 39
2014
Q1 		$7.49M Sell
109,837
-52,144
-32% -$3.84M 1.22% 33
2013
Q4 		$11.4M Buy
161,981
+36,844
+29% +$2.5M 1.93% 5
2013
Q3 		$9.03M Sell
125,137
-12,491
-9% -$830K 1.78% 8
2013
Q2 		$7.67M Buy
+137,628
New +$8.58M 1.56% 21

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantum Capital Management (California)'s BMRN Position: Q1 2019 in Review

Quantum Capital Management (California) sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2019, closing a stake of 5,885 shares — an estimated $501K sold.

Quantum Capital Management (California) first reported a position in BMRN in Q2 2013 and held it in 21 quarters. The position peaked at $14.3M in Q1 2016. 486 funds tracked by Wall St. Rank hold BMRN as of Q1 2019.

  • Quantum Capital Management (California) reported no remaining BioMarin Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Quantum Capital Management (California) sold 5,885 BioMarin Pharmaceuticals shares in Q1 2019, an estimated $501K.
  • Quantum Capital Management (California) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Quantum Capital Management (California)'s BioMarin Pharmaceuticals position peaked at $14.3M in Q1 2016.
  • 486 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2019.

Based on Quantum Capital Management (California)'s 13F filing for Q1 2019, filed 3 May 2019.